Nextar Life Sciences Private Limited
About Nextar Life Sciences Private Limited
Data last updated:
Nextar Life Sciences Private Limited is a private limited company based in Thiruvananthapuram, Kerala, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 18 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U52311KL2011PTC027722. Its GSTIN is 32AADCN5545P1Z4 (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sujith Kumar Sreekantan and Vasanthakumari Madhusoodhanan Pillai Vijith.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tc 70/2328 – 2 Uthram Attukal Manacaud Po, Thiruvananthapuram, Kerala, India – 695009.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.98 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.19 Lakh (net margin 1.6%) and EBITDA of ₹2.73 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nextar Life Sciences Private Limited's registered office is in Thiruvananthapuram, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressTc 70/2328 – 2 Uthram Attukal Manacaud Po, Thiruvananthapuram, Kerala, India – 695009
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Nextar Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nextar Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nextar Life Sciences Private Limited, buy the company report.
Financials of Nextar Life Sciences Private Limited
FY 2025 filings availableNextar Life Sciences Private Limited reported revenue of ₹73.98 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nextar Life Sciences Private Limited, buy the company report.
Board of directors of Nextar Life Sciences Private Limited
Nextar Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujith Kumar Sreekantan | Director | 18 Feb 2011 | 15 Years 8 Months | Current |
| Vasanthakumari Madhusoodhanan Pillai Vijith | Director | 18 Feb 2011 | 15 Years 8 Months | Current |
Peer comparison
Nextar Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Delusso Gems & Jewels Private Limited | ₹74.01 Lakh (FY 2025) | 33.0% | Gurgaon, Haryana, India | |||
| TCGL Agro Industries Private Limited | ₹73.99 Lakh (FY 2024) | 40.0% | Pune, Maharashtra, India | |||
| Shree Ikonply Private Limited | ₹73.99 Lakh (FY 2025) | 407.0% | Bhubaneswar, Odisha, India | |||
| Aay Jay Media Solutions Private Limited | ₹73.99 Lakh (FY 2025) | -64.0% | Kanpur, Uttar Pradesh, India | |||
| Christy Comtrade Private Limited | ₹73.98 Lakh (FY 2017) | 150.0% | Ahmedabad, Gujarat, India | |||
| Nextar Life Sciences Private Limitedthis company | ₹73.98 Lakh (FY 2025) | ₹1.19 Lakh | 1.6% | -8.0% | Thiruvananthapuram, Kerala, India | |
| Circles Utility Management Private Limited | ₹73.96 Lakh (FY 2022) | 6.0% | Mogappair East, Chennai, Tamil Nadu, India | |||
| Lucksworth Trading Private Limited | ₹73.96 Lakh (FY 2024) | Delhi, India | ||||
| B L Ladha and Sons Private Limited | ₹73.96 Lakh (FY 2024) | -3.0% | Varanasi, Uttar Pradesh, India | |||
| Manobina Enterprise(India) Private Limited | ₹73.96 Lakh (FY 2025) | 104.0% | Kolkata, West Bengal, India | |||
| Futuretech Life Care Private Limited | ₹73.96 Lakh (FY 2025) | -32.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Nextar Life Sciences Private Limited, buy the company report.
Auditor
Nextar Life Sciences Private Limited is audited by NATARAJAN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NATARAJAN & ASSOCIATES | FY 2017 | 013842S |
Shareholding
The shareholding of Nextar Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nextar Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nextar Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nextar Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nextar Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AADCN5545P1Z4 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nextar Life Sciences Private Limited, buy the company report.
Recent activity
Nextar Life Sciences Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Sujith Kumar Sreekantan was appointed as Director on 18 Feb 2011.
Frequently asked questions
Nextar Life Sciences is an active private limited company based in Thiruvananthapuram, Kerala, India. The company works in wholesale, within the trading industry. It was incorporated on 18 February 2011 (15+ years old) and is registered under CIN U52311KL2011PTC027722.
Nextar Life Sciences has 2 current directors:
- Sujith Kumar Sreekantan - Director
- Vasanthakumari Madhusoodhanan Pillai Vijith - Director
The latest financial statements of Nextar Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nextar Life Sciences is 32AADCN5545P1Z4, registered in Kerala.
The CIN (Corporate Identification Number) of Nextar Life Sciences is U52311KL2011PTC027722. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nextar Life Sciences was incorporated on 18 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Nextar Life Sciences by revenue are Delusso Gems & Jewels Private Limited, TCGL Agro Industries Private Limited, Shree Ikonply Private Limited, Aay Jay Media Solutions Private Limited, Christy Comtrade Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sujith Kumar Sreekantan was appointed as Director on 18 Feb 2011. Vasanthakumari Madhusoodhanan Pillai Vijith was appointed as Director on 18 Feb 2011.
The registered office of Nextar Life Sciences is at Tc 702328 – 2 Uthram Attukal Manacaud Po, Thiruvananthapuram, Kerala, India – 695009.
Nextar Life Sciences operates in the trading industry, in the wholesale segment.
The compliance status of Nextar Life Sciences is compliant as of 13 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
